Page last updated: 2024-09-04

glucagon and Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness

glucagon has been researched along with Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heinla, I; Jagomäe, T; Koppel, T; Pallase, M; Plaas, M; Seppa, K; Terasmaa, A; Toots, M; Vasar, E	1

Other Studies

1 other study(ies) available for glucagon and Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness

Article	Year
Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome. Scientific reports, 2018, 07-05, Volume: 8, Issue:1 Topics: Animals; Blood Glucose; Calmodulin-Binding Proteins; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Knockout Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Injections, Subcutaneous; Insulin; Islets of Langerhans; Liraglutide; Male; Membrane Proteins; Rats; Rats, Transgenic; Treatment Outcome; Wolfram Syndrome	2018

Article

Year

Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome.

Scientific reports, 2018, 07-05, Volume: 8, Issue:1

Topics: Animals; Blood Glucose; Calmodulin-Binding Proteins; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Knockout Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Injections, Subcutaneous; Insulin; Islets of Langerhans; Liraglutide; Male; Membrane Proteins; Rats; Rats, Transgenic; Treatment Outcome; Wolfram Syndrome

2018